The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with neuroprotection
- 13 July 2009
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 110 (3) , 1107-1119
Abstract
In this study, we provide evidence that the muscarinic M1 receptor targets NF‐E2‐related factor‐2 (Nrf2), a transcription factor that regulates the expression of genes containing antioxidant response elements (AREs) in their promoters and that collectively constitute the phase II antioxidant response. In hippocampal primary and cerebellar granule neuron cultures expressing endogenous M1 receptor, carbachol increased the levels of a prototypical phase II antioxidant enzyme, heme oxygenase‐1. Moreover, in a heterologous system, based on lentiviral expression of M1 receptor in PC12 pheochromocytoma cells, we found that M1 increased total and nuclear Nrf2 protein levels and heme oxygenase‐1 messenger RNA and protein levels. Luciferase reporter constructs for AREs and the use of two inhibitors of protein kinase C (PKC), chelerythrine and 2‐aminoethyl diphenylborinate, or transfection with relevant expression vectors allowed us to identify Gαq, phospholipase C‐β and the classical PKC‐γ isoenzyme, as responsible for the regulation of Nrf2. A PKC‐insensitive Nrf2S40A single‐point mutant partially channeled M1 signaling to AREs, therefore suggesting the participation of additional intermediates. Inhibition of glycogen synthase kinase‐3β (GSK‐3β) augmented M1‐dependent activation of AREs while a PKC‐insensitive mutant of GSK‐3β (GSK‐3β‐Δ9) blocked this effect and prevented M1‐induced accumulation of Nrf2 in the nucleus. Our results demonstrate a previously unidentified role of the Gαq/phospholipase C‐β/PKC/GSK‐3β axis in regulation of Nrf2 by M1. Such role provides additional conceptual support for the use of cholinemimetics in the treatment of pathologies that, like Alzheimer’s disease, require a reinforcement of the cell antioxidant capacity.Keywords
This publication has 54 references indexed in Scilit:
- Role of Gα12 and Gα13 as Novel Switches for the Activity of Nrf2, a Key Antioxidative Transcription FactorMolecular and Cellular Biology, 2007
- Role of protein kinase C δ in curcumin-induced antioxidant response element-mediated gene expression in human monocytesBiochemical and Biophysical Research Communications, 2006
- Regulation of Cu/Zn-Superoxide Dismutase Expression via the Phosphatidylinositol 3 Kinase/Akt Pathway and Nuclear Factor-κBThe Journal of Neuroscience, 2004
- Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine‐induced status epilepticus with special reference to CA1 area and the dentate gyrusHippocampus, 2003
- Phosphorylation of glycogen synthase kinase-3β at serine-9 by phospholipase Cγ1 through protein kinase C in rat 3Y1 fibroblastsExperimental & Molecular Medicine, 2002
- Activation of Akt/Protein Kinase B by G Protein-coupled ReceptorsJournal of Biological Chemistry, 1998
- Activation of Muscarinic Receptors Inhibits Apoptosis in PC12M1 CellsJournal of Neurochemistry, 1995
- Growth Factor‐Like Effects Mediated by Muscarinic Receptors in PC12M1 CellsJournal of Neurochemistry, 1992
- Studies on the primary sequence requirements for PKC‐α, ‐β1 and ‐γ peptide substratesFEBS Letters, 1990
- Expression of protein kinase C I in NIH 3T3 cells increases its growth response to specific activatorsFEBS Letters, 1990